These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11226762)

  • 1. The changeable nature of patients' fears regarding chemotherapy: implications for palliative care.
    Passik SD; Kirsh KL; Rosenfeld B; McDonald MV; Theobald DE
    J Pain Symptom Manage; 2001 Feb; 21(2):113-20. PubMed ID: 11226762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.
    Schwartzberg LS; Modiano MR; Rapoport BL; Chasen MR; Gridelli C; Urban L; Poma A; Arora S; Navari RM; Schnadig ID
    Lancet Oncol; 2015 Sep; 16(9):1071-1078. PubMed ID: 26272768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does assessing patients' expectancies about chemotherapy side effects influence their occurrence?
    Colagiuri B; Dhillon H; Butow PN; Jansen J; Cox K; Jacquet J
    J Pain Symptom Manage; 2013 Aug; 46(2):275-81. PubMed ID: 23149081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials.
    Rapoport BL; Chasen MR; Gridelli C; Urban L; Modiano MR; Schnadig ID; Poma A; Arora S; Kansra V; Schwartzberg LS; Navari RM
    Lancet Oncol; 2015 Sep; 16(9):1079-1089. PubMed ID: 26272769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life.
    Rha SY; Lee J
    Support Care Cancer; 2017 May; 25(5):1519-1527. PubMed ID: 28032218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of anticipatory nausea and vomiting in chemotherapy patients.
    Morrow GR
    J Natl Cancer Inst; 1982 Apr; 68(4):585-8. PubMed ID: 6951074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaps exist between patients' experience and clinicians' awareness of symptoms after chemotherapy: CINV and accompanying symptoms.
    Rha SY; Song SK; Lee CE; Park Y; Lee J
    Support Care Cancer; 2016 Nov; 24(11):4559-66. PubMed ID: 27278273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on symptom control of structured information given to patients receiving chemotherapy.
    Mollaoğlu M; Erdoğan G
    Eur J Oncol Nurs; 2014 Feb; 18(1):78-84. PubMed ID: 24095215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapy.
    Marchioro G; Azzarello G; Viviani F; Barbato F; Pavanetto M; Rosetti F; Pappagallo GL; Vinante O
    Oncology; 2000 Aug; 59(2):100-4. PubMed ID: 10971166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study].
    Nukariya N; Kobayashi K; Ishihara Y; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
    Gan To Kagaku Ryoho; 1996 May; 23(6):757-71. PubMed ID: 8645027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patient perceptions of the side effects of cancer chemotherapy.
    Carelle N; Piotto E; Bellanger A; Germanaud J; Thuillier A; Khayat D
    Cancer; 2002 Jul; 95(1):155-63. PubMed ID: 12115329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient's anxiety and fear of anesthesia: effect of gender, age, education, and previous experience of anesthesia. A survey of 400 patients.
    Mavridou P; Dimitriou V; Manataki A; Arnaoutoglou E; Papadopoulos G
    J Anesth; 2013 Feb; 27(1):104-8. PubMed ID: 22864564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural factors influencing the development and expression of chemotherapy induced side effects.
    Morrow GR
    Br J Cancer Suppl; 1992 Dec; 19():S54-60; discussion S60-3. PubMed ID: 1467203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom Prevalence and Related Distress in Cancer Patients Undergoing Chemotherapy.
    Thiagarajan M; Chan CM; Fuang HG; Beng TS; Atiliyana MA; Yahaya NA
    Asian Pac J Cancer Prev; 2016; 17(1):171-6. PubMed ID: 26838205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).
    Kottschade L; Novotny P; Lyss A; Mazurczak M; Loprinzi C; Barton D
    Support Care Cancer; 2016 Jun; 24(6):2661-7. PubMed ID: 26768436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and clinical implications of delayed nausea and delayed emesis.
    Morrow GR; Hickok JT; Burish TG; Rosenthal SN
    Am J Clin Oncol; 1996 Apr; 19(2):199-203. PubMed ID: 8610650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guided Imagery And Progressive Muscle Relaxation as a Cluster of Symptoms Management Intervention in Patients Receiving Chemotherapy: A Randomized Control Trial.
    Charalambous A; Giannakopoulou M; Bozas E; Marcou Y; Kitsios P; Paikousis L
    PLoS One; 2016; 11(6):e0156911. PubMed ID: 27341675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer.
    Sun CC; Bodurka DC; Weaver CB; Rasu R; Wolf JK; Bevers MW; Smith JA; Wharton JT; Rubenstein EB
    Support Care Cancer; 2005 Apr; 13(4):219-27. PubMed ID: 15538640
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.